Remember all those perks designed to get you to get your COVID shot? They're still around, apparently, and if you haven't had your omicron booster yet, you may want to check this out.
The decision is still awaiting approval, and a recent poll shows that
on whether or not their tax-paying dollars should go towards financial incentives for receiving the new booster.If you're not a resident of Massachusetts or Washington state, there are some financial incentives you may be eligible to receive.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
China Struggles With COVID Wave After 'Zero-COVID' EasesA rash of COVID-19 cases in schools and businesses were reported by social media users Friday in areas across China after the ruling Communist Party loosened anti-virus rules as it tries to reverse a deepening economic slump.
Lire la suite »
COVID is creeping up in Ohio, yet very few have gotten updated boosterThe number of people being hospitalized for COVID in Ohio is starting to creep up again, while only about 10% of the state has taken the updated booster according to the Ohio Department of Health’s (ODH) dashboard.
Lire la suite »
Some children as young as 6 months now eligible for COVID-19 booster shotsAlthough the updated boosters have been available since September, only a small percentage of Americans have gotten one.
Lire la suite »
FDA says some young kids can't get an updated COVID booster until next yearThe FDA says it is waiting for data to be submitted next year to clear shots for some of the youngest Pfizer vaccine recipients.
Lire la suite »
FDA clears bivalent COVID-19 booster shots for children under 5The FDA has authorized use of the tweaked shots starting at age 6 months, but just who is eligible depends on how many vaccinations they’ve already had. FOX13
Lire la suite »
FDA authorizes updated Covid booster shots for kids under 5The omicron-targeted vaccines made by Moderna and Pfizer will become available to children ages 6 months and older after the CDC signs off.
Lire la suite »